Abstract
New treatments offer hope but await regulatory approval in the UK
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Carcinoma, Renal Cell / drug therapy*
-
Epidermal Growth Factor / antagonists & inhibitors*
-
Humans
-
Kidney Neoplasms / drug therapy*
Substances
-
Antineoplastic Agents
-
Epidermal Growth Factor